Pretransfusion Testing and Daratumumab: Assessing Interference Risks and Developing Solutions
Daratumumab is a monoclonal antibody; anti-CD38 is used for the treatment of multiple myeloma and other hematological disorders. Daratumumab, binds to CD 38 on red blood cells (RBCs), interfering with pretransfusion testing. This interference can lead to cross match incompatibility and panreactive i...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer Medknow Publications
2024-05-01
|
| Saila: | Global Journal of Transfusion Medicine |
| Gaiak: | |
| Sarrera elektronikoa: | https://journals.lww.com/10.4103/gjtm.gjtm_52_23 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|